You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
|
|---|---|
| Published in |
Frontiers in Pharmacology, June 2021
|
| DOI | 10.3389/fphar.2021.625296 |
| Pubmed ID | |
| Authors |
Sabine Vogler, Peter Schneider, Martin Zuba, Reinhard Busse, Dimitra Panteli |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 25% |
| Belgium | 1 | 13% |
| Switzerland | 1 | 13% |
| Unknown | 4 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 63% |
| Practitioners (doctors, other healthcare professionals) | 2 | 25% |
| Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 64 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 9 | 14% |
| Researcher | 9 | 14% |
| Other | 5 | 8% |
| Student > Bachelor | 5 | 8% |
| Student > Ph. D. Student | 3 | 5% |
| Other | 6 | 9% |
| Unknown | 27 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 11% |
| Nursing and Health Professions | 5 | 8% |
| Economics, Econometrics and Finance | 5 | 8% |
| Business, Management and Accounting | 3 | 5% |
| Social Sciences | 3 | 5% |
| Other | 10 | 16% |
| Unknown | 31 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2023.
All research outputs
#2,824,496
of 23,993,601 outputs
Outputs from Frontiers in Pharmacology
#1,131
of 17,837 outputs
Outputs of similar age
#67,183
of 431,074 outputs
Outputs of similar age from Frontiers in Pharmacology
#48
of 916 outputs
Altmetric has tracked 23,993,601 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,837 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,074 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 916 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.